Cite

HARVARD Citation

    Murai, K. et al. (2021). Low-dose dasatinib in older patients with chronic myeloid leukaemia in chronic phase (DAVLEC): a single-arm, multicentre, phase 2 trial. Lancet. 8 (12), pp. e902-e911. [Online]. 
  
Back to record